Literature DB >> 24752804

The first indoleamine-2,3-dioxygenase-1 (IDO1) inhibitors containing carborane.

Christopher J D Austin1, Jan Kahlert, Fatiah Issa, John H Reed, Jason R Smith, Joseph A Ioppolo, Jennifer A Ong, Joanne F Jamie, David Hibbs, Louis M Rendina.   

Abstract

Indoleamine-2,3-dioxygenase-1 (IDO1) is a critical immunoregulatory enzyme responsible for the metabolism of tryptophan during inflammation and disease. Based upon a pyranonaphthoquinone framework, the first examples of indoleamine-2,3-dioxygenase-1 (IDO1) inhibitors containing a carborane cage are reported. The novel closo-1,2-carboranyl-N-pyranonaphthoquinone derivatives display low μM binding affinity for the human recombinant enzyme, with IC50 values ranging from 0.78 to 1.77 μM.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24752804     DOI: 10.1039/c4dt00444b

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  3 in total

Review 1.  Recent advances in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.

Authors:  Xiu-Xiu Wang; Si-Yu Sun; Qing-Qing Dong; Xiao-Xiang Wu; Wei Tang; Ya-Qun Xing
Journal:  Medchemcomm       Date:  2019-08-15       Impact factor: 3.597

2.  Erylusamides: Novel Atypical Glycolipids from Erylus cf. deficiens.

Authors:  Helena Gaspar; Adele Cutignano; Laura Grauso; Nuno Neng; Vasco Cachatra; Angelo Fontana; Joana Xavier; Marta Cerejo; Helena Vieira; Susana Santos
Journal:  Mar Drugs       Date:  2016-10-11       Impact factor: 5.118

3.  Insights from the predicted structural analysis of carborane substituted withaferin A with Indoleamine - 2,3-dioxygenase as a potent inhibitor.

Authors:  Syed Hussain Basha; Abhishek Thakur; Firoz A Samad
Journal:  Bioinformation       Date:  2016-11-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.